Wink LK, Adams R, Wang Z, Klaunig JE, Plawecki MH, Posey DJ, McDougle CJ, Erickson CA
For example, in liraglutide trials, 24.7% of participants reported nausea at week 4, but this dropped to 14.7% by week 8 and just 5.5% by week 56
If youre ready to regain control of your health and achieve lasting results, schedule a consultation today to learn how GLP-1 weight loss shots can help transform your journey.
Bibcode:2003PNAS..100.9785L
10.1186/s11658-026-00944-6 107 MeshramM
It also creates significant opportunities for biopharma - enabling more precise patient stratification for clinical trials, improving probability of success in indication expansion, and supporting post-marketing differentiation by identifying the right drug for the right patient